a, a N Clinical Trials

A listing of a, a N clinical trials actively recruiting patients volunteers.

Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 1940 clinical trials
Dose Escalation Study of Intravitreal 4D-110 in Patients With Choroideremia

This study will evaluate safety, tolerability, and preliminary efficacy of a single intravitreal (IVT) injection of a recombinant adeno-associated virus (AAV) gene therapy, 4D-110, in male patients with genetically-confirmed Choroideremia (CHM).

  • 0 views
  • 19 Feb, 2024
  • 2 locations
TTNS Versus Sham Therapy for Children With iOAB (TaPaS Part I)

Part I of the TaPaS trial forms part of a twofold clinical RCT: Part 1) A prospective RCT comparing the efficacy of transcutaneous tibial nerve stimulation (TTNS) with TTNS sham therapy for children with idiopathic overactive bladder on clinical and patient reported outcomes (PROMS).

overactive bladder
sham therapy
percutaneous tibial nerve stimulation
incontinence
  • 0 views
  • 19 Feb, 2024
  • 1 location
AAV Gene Therapy Clinical Study in Adult Classic PKU (PHEdom)

NGGT002 is an rAAV8 based vector carrying a functional copy of the human PAH gene.Participants will receive a single administration of NGGT002 and will be followed for safety and efficacy for 5 years.

  • 0 views
  • 09 May, 2025
  • 2 locations
SPEARHEAD 2 Study in Subjects With Recurrent or Metastatic Head and Neck Cancer

This is a study to investigate the efficacy and safety of ADP-A2M4 in combination with pembrolizumab in HLA-A*02 eligible and MAGE-A4 positive subjects with recurrent or metastatic Head and Neck cancer.

metastatic head and neck cancer
metastatic head and neck carcinoma
metastasis
squamous cell carcinoma of head and neck
cancer
  • 0 views
  • 19 Feb, 2024
  • 1 location
Upper Limb Loss Perturbation Response

Recent investigations have suggested that persons with upper limb loss experience a high prevalence of falls with a quarter of reported falls resulting from a trip. Moreover, studies indicate that missing part of an arm may negatively impact balance and that use of a prosthesis exacerbates this problem.

limb amputation
fatigue
upper limb
  • 0 views
  • 19 Feb, 2024
  • 1 location
Expertise Asthma COPD Program with Digital Support (EXACT@home)

One the devices that will be used is also a medicinal product: a digital inhaler, which monitors adherence and inhaler technique through its connected application and aims to improve adherence and inhaler technique with reminders and notifications.

  • 0 views
  • 13 Mar, 2026
Study of Single-dose DS-3201b in Participants With Hepatic Impairment

This is a Phase 1, open-label, parallel design, single-dose pharmacokinetic (PK) study to assess the safety, tolerability, and PK of a single dose of 50 mg of DS-3201b in participants with normal and impaired hepatic function.

follicle stimulating hormone
moderate hepatic insufficiency
hepatic impairment
hepatitis
gilbert's syndrome
  • 0 views
  • 19 Feb, 2024
  • 3 locations
4SCAR-T Therapy Post CD19-targeted Immunotherapy

Clinical response and optiminzation of a standardized lentiviral vector and cell production protocol will be investigated. This is a phase I/II trial enrolling patients from multiple clinical centers.

  • 0 views
  • 19 Feb, 2024
  • 3 locations
Neoadjuvant Irradiation of Retroperitoneal Soft Tissue Sarcoma With Ions Retro-Ion

The study is a randomized, open, prospective phase II study. The aim of the study is to evaluate the safety and feasibility of a hypofractionated, accelerated radiation approach based on the incidence of grade 3-5 NCI Common Terminology Criteria for Adverse Events (NCI-CTC-AE ) toxicity and / or termination of …

  • 0 views
  • 19 Feb, 2024
  • 1 location
ADME Study of Acoziborole in Healthy Subjects

All subjects will receive an oral dose of 960 mg [14C] acoziborole on a single occasion as 4 capsules containing a small amount of radioactivity (not more than [NMT] 1000 nCi [37 KBq] 14C).

  • 0 views
  • 19 Feb, 2024
  • 1 location